Modulation of UDP-glucuronosyltransferase activity by protein-protein association

Drug Metabolism Reviews

Volumn 42, Issue 1, 2010, Pages 145-158

  Ishii, Yuji ^a   Takeda, Shuso ^a,b   Yamada, Hideyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

Cytochrome P450; Drug metabolism; Glucuronidation; Protein protein interaction; UDP glucuronosyltransferase

Indexed keywords

4 NITROPHENOL; CHLORAMPHENICOL; CYTOCHROME P450; CYTOCHROME P450 3A4; ESTRIOL; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 2B7; HETERODIMER; ISOENZYME; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; SEROTONIN; TESTOSTERONE; ZIDOVUDINE;

DRUG CONJUGATION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG OXIDATION; ENDOPLASMIC RETICULUM; ENZYME SPECIFICITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 74549143382     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602530903208579     Document Type: Review

References (94)

1. Alston, K., Robinson, R. C., Park, S. S., Gelboin, H. V., Friedman, F. K. (1991). Interactions among cytochromes P450 in the endoplas-mic reticulum. Detection of chemically cross-linked complexes with monoclonal antibodies. J Biol Chem 266:735-739.
2. Baulieu, M., Lévesque E., Hum, D. W., Bélanger, A. (1998). Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 248:44-50.
3. Bock, K. W., Josting, D., Lilienblum, W., Pfeil, H. (1979). Purifcation of rat-liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital. Eur J Biochem 98:19-26.
4. Bock, K. W., Köhle, C. (2009). Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions. Biochem Pharmacol 77:1458-1465.
5. Bock, K. W., Lilienblum, W. (1979). Activation and induction of rat-liver microsomal UDP-glucuronyltransferase with 6-hydroxybenzo(a)pyrene and N-hydroxy-2-naphthylamine as substrates. Biochem Pharmacol 28:695-700.
6. Cofman, B. L., Rios, G. R., King, C. D., Tephly, T. R. (1997). Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1-4.
7. Cosme, J., Johnson, E. F. (2000). Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding. J Biol Chem 275:2545-2553.
8. Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., Von Moltke, L. L., et al. (2003). Evaluation of 3'-azido-3'-de-oxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specifcity and infuence of the UGT2B7*2 polymorphism. Drug Metab Dispos 31:1125-1133.
9. Davydov, D. R., Knyushko, T. V., Hoa, G. H. (1992). High-pressure-induced inactivation of ferrous cytochrome P450 LM2 (IIB4) CO complex: evidence for the presence of two conformers in the oligomer. Biochem Biophys Res Commun 188:216-221.
10. Edwards, R. J., Murray, B. P., Singleton, A. M., Boobis, A. R. (1991). Orientation of cytochrome P450 in the endoplasmic reticulum. Biochemistry 30:71-76.
11. Evans, W. E., Relling, M. V. (1999). Pharmacogenomics: translating functional genomics into rational therapeutics, Science 286:487-491.
12. Falany, C. N., Green, M. D., Tephly, T. R. (1987). Te enzymatic mechanism of glucuronidation catalyzed by two purifed rat-liver steroid UDP-glucuronosyltransferases. J Biol Chem 262:1218-1222.
13. Falany, C. N., Tephly, T. R. (1983). Separation, purifcation, and characterization of three isoenzymes of UDP-glucuronyltransferase from rat-liver microsomes. Arch Biochem Biophys 227:248-258.
14. Finel, M., Kurkela, M. (2008). Te UDP-glucuronosyltransferases as oligomeric enzymes. Curr Drug Metab 9:70-76.
15. Fremont, J. J., Wang, R. W., King, C. D. (2005). Coimmunoprecipitation of UDP-glucuronosyltransferase (UGT) isoforms and cyto-chrome P450 3A4. Mol Pharmacol 67:260-262.
16. Fretland, A. J., Omiecinski, C. J. (2000). Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact 129:41-59.
17. Fujiwara, R., Nakajima, M., Oda, S., Yamanaka, H., Ikushiro, S. I., Sakaki, T., et al. (2009). Interactions between human UDP- glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes. J Pharm Sci May 27. [Epub ahead of print].
18. Fujiwara, R., Nakajima, M., Yamanaka, H., Katoh, M., Yokoi, T. (2007a). Interactions between human UGT1A1, UGT1A4, and UGT1A6 afect their enzymatic activities. Drug Metab Dispos 35:1781-1787.
19. Fujiwara, R., Nakajima, M., Yamanaka, H., Nakamura, A., Katoh, M., Ikushiro, S., et al. (2007b). Efects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. Drug Metab Dispos 35:747-757.
20. Ghosh, S. S., Sappal, B. S., Kalpana, G. V., Lee, S. W., Roy Chowdhury J., Roy Chowdhury, N. (2001). Homodimerization of human bilirubin-uridine- diphosphoglucuronate glucuronosyltrans-ferase-1 (UGT1A1) and its functional implications. J Biol Chem 276:42108-42115.
21. Girard, H., Lévesque, E., Bellemare, J., Journault, K., Caillier, B., Guillemette, C. (2007). Genetic diversity at the UGT1 locus is amplifed by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glu-curonidation activity. Pharmacogenet Genom 17:1077-1089.
22. Gotoh, O. (1992). Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem 267:83-90.
23. Green, M. D., Bélanger, G., Hum, D. W., Bélanger, A., Tephly, T. R. (1997). Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalyzed by expressed monkey UDP-glucuronosyltransferase 2B9 protein. Drug Metab Dispos 25:1389-1394.
24. Grove, A. D., Kessler, F. K., Metz, R. P., Ritter, J. K. (1997). Identifcation of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydro-diol. J Biol Chem 272:1621-1627.
25. Gschaidmeier, H., Bock, K. W. (1994). Radiation inactivation analysis of microsomal UDP-glucuronosyltransferases catalysing mono-and diglucuronide formation of 3,6-dihydroxybenzo(a)pyrene and 3,6-dihydroxychrysene. Biochem Pharmacol 48:1545-1549.
26. Guillemette, C., Lévesque, E., Bellemare, J., Harvey, M., Ménard, V., Girard, H. (2010). UDP-glucuronosyltransferase (UGT) enzyme diversity: beyond gene duplication. Drug Metab Rev. In press.
27. Hochman, Y., Kelley, M., Zakim, D. (1983). Modulation of the number of ligand binding sites of UDP-glucuronyltransferase by the gel to liquid-crystal phase transition of phosphatidylcholines. J Biol Chem 258:6509-6516.
28. Ikushiro, S., Emi, Y., Iyanagi, T. (1997). Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry 36:7154-7161.
29. Ikushiro, S., Kominami, S., Takemori, S. (1992). Adrenal P-450scc modulates activity of P-45011 beta in liposomal and mitochon-drial membranes. Implication of P-450scc in zone specifcity of aldosterone biosynthesis in bovine adrenal. J Biol Chem 267:1464-1469.
30. Ikushiro, S., Sahara, M., Emi. Y., Yabusaki, Y., Iyanagi, T. (2004). Functional coexpression of xenobiotic metabolizing enzymes, rat cytochrome P450 1A1 and UDP-glucuronosyltransferase 1A6, in yeast microsomes. Biochim Biophys Acta 1672:86-92.
31. Ishii, Y., Iwanaga, M., Nishimura, Y., Takeda, S., Ikushiro, S., Nagata, K., et al. (2007). Protein-protein interactions between rat hepatic cytochromes P450 (P450s) and UDP-glucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex. Drug Metab Pharmacokinet 22:367-376.
32. Ishii, Y., Miyoshi, A., Maji, D., Yamada, H., Oguri, K. (2004). Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed chloramphenicol glucuronidation. Drug Metab Dispos 32:1057-1060.
33. Ishii, Y., Miyoshi, A., Watanabe, R., Tsuruda, K., Tsuda, M., Yamaguchi-Nagamatsu, Y., et al. (2001). Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation. Mol Pharmacol 60:1040-1048.
34. Ishii, Y., Oguri, K., Yoshimura, H. (1993). Purifcation and characterization of a morphine UDP-glucuronyltransferase isoform from untreated rat liver. Biol Pharm Bull 16:754-758.
35. Ishii, Y., Takeda, S., Yamada, H., Oguri, K. (2005). Functional protein-protein interaction of drug-metabolizing enzymes. Front Biosci 10:887-895.
36. Iyanagi, T., Haniu, M., Sogawa, K., Fujii-Kuriyama, Y., Watanabe, S., Shively, J. E., Anan, K.F. (1986) Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J Biol Chem 261:15607-15614.
37. Iyanagi, T. (2007). Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxication. Int Rev Cytol 260:35-112.
38. Jackson, M. R., Nilsson, T., Peterson, P. A. (1990). Identifcation of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 9:3153-3162.
39. Kim, K. H., Ahn, T., Yun, C. H. (2003). Membrane properties induced by anionic phospholipids and phosphatidylethanolamine are critical for the membrane-binding and catalytic activity of human cytochrome P450 3A4. Biochemistry 42:15377-15387.
40. Koiwai, O., Aono, S., Adachi, Y., Kamisako, T., Yasui, Y., Nishizawa, M., et al. (1996). Crigler-Najjar syndrome type II is inherited both as a dominant and as a recessive trait. Hum Mol Genet 5:645-647.
41. Kominami, S., Harada, D., Takemori, S. (1994). Regulation mechanism of the catalytic activity of bovine adrenal cytochrome P-450 11 beta. Biochim Biophys Acta 1192:234-240.
42. Kuo, C. K., Hanioka, N., Hoshikawa, Y., Oguri, K., Yoshimura, H. (1991). Species diference of site-selective glucuronidation of morphine. J Pharmacobio-Dyn 14:187-193.
43. Kurkela, M., Garcia-Horsman, J. A., Luukkanen, L., Morsky, S., Taskinen, J., Baumann, M., et al. (2003). Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purifed as an active dimeric enzyme. J Biol Chem 278:3536-3544.
44. Kurkela, M., Hirvonen, J., Kostiainen, R., Finel, M. (2004b). Te interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specifc, and may involve both monomers. Biochem Pharmacol 68:2443-2450.
45. Kurkela, M., Morsky, S., Hirvonen, J., Kostiainen, R., Finel, M. (2004a). An active and water-soluble truncation mutant of the human UDP- glucuronosyltransferase 1A9. Mol Pharmacol 65:826-831.
46. Kurkela, M., Patana, A. S., Mackenzie, P. I., Court, M. H., Tate, C. G., Hirvonen, J., et al. (2007). Interactions with other human UDP- glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate afnity of UGT1A6. Pharmacogenet Genom 17:115-126.
47. Lewis, D. F., Modi, S., Dickins, M. (2002). Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab Rev 34:69-82.
48. Lévesque, E., Girard, H., Journaultm K., Lépinem J., Guillemettem C. (2007). Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 45:128-138.
49. Mackenzie, P. I. (1986a). Rat-liver UDP-glucuronosyltransferase. Sequence and expression of a cDNA encoding a phenobarbital-inducible form. J Biol Chem 261:6119-6125.
50. Mackenzie, P. I. (1986b). Rat-liver UDP-glucuronosyltransferase. cDNA sequence and expression of a form glucuronidating 3-hy-droxyandrogens. J Biol Chem 261:14112-14117.
51. Mackenzie, P. I. (1987). Rat-liver UDP-glucuronosyltransferase. Identifcation of cDNAs encoding two enzymes which glucuro-nidate testosterone, dihydrotestosterone, and beta-estradiol. J Biol Chem 262:9744-9749.
52. Mackenzie, P. I. (1990). Te cDNA sequence and expression of a variant 17beta-hydroxysteroid UDP-glucuronosyltransferase. J Biol Chem 265:8699-8703.
53. Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP-glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677-685.
54. Mackenzie, P. I., Hjelmeland, L. M., Owens, I. S. (1984). Purifcation and immunochemical characterization of a low-pI form of UDP-glucuronosyltransferase from mouse liver. Arch Biochem Biophys 231: 487-497.
55. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Bélanger, A., et al. (1997). Te UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
56. Mackenzie, P. I., Rodbourn, L., Iyanagi, T. (1993). Glucuronidation of carcinogen metabolites by complementary DNA-expressed uridine 5'-diphosphate glucuronosyltransferases. Cancer Res 53:1529-1533.
57. Matern, H., Matern, S., Gerok, W. (1982). Isolation and characterization of rat-liver microsomal UDP-glucuronosyltransferase activity toward chenodeoxycholic acid and testosterone as a single form of enzyme. J Biol Chem 257:7422-7429.
58. Matsui, M., Nagai, F. (1986). Genetic defciency of androsterone UDP-glucuronosyltransferase activity in Wistar rats is due to the loss of enzyme protein. Biochem J 234:139-144.
59. Meech, R., Mackenzie, P. I. (1997a). Structure and function of urid-ine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 24:907-915.
60. Meech, R., Mackenzie, P. I. (1997b). UDP-glucuronosyltransferase, the role of the amino terminus in dimerization. J Biol Chem 272:26913-26917.
61. Meech, R., Mackenzie, P. I. (1998). Determinants of UDP- glucuronosyltransferase membrane association and residency in the endoplasmic reticulum. Arch Biochem Biophys 356:77-85.
62. Meech, R., Yogalingam, G., Mackenzie, P. I. (1996). Mutational analysis of the carboxy-terminal region of UDP-glucuronosyltransferase 2B1. DNA Cell Biol 15:489-494.
63. Myasoedova, K. N., Tsuprun, V. L. (1993). Cytochrome P450: hexam-eric structure of the purifed LM4 form. FEBS Lett 325:251-254.
64. Nagar, S., Zalatoris, J. J., Blanchard, R. L. (2004). Human UGT1A6 pharmacogenetics: identifcation of a novel SNP, characterization of allele frequencies, and functional analysis of recom-binant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 14:487-499.
65. Nagata, K., Ozawa, S., Miyata, M., Shimada, M., Yamazoe, Y., Kato, R. (1994). Primary structure and molecular basis of polymorphic appearance of an acetyltransferase (AT-II)* in hamsters. Pharmacogenetics 4:91-100.
66. Nakajima, M., Yamanaka, H., Fujiwara, R., Katoh, M., Yokoi, T. (2007). Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phe-nylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: efects of UGT-UGT interactions. Drug Metab Dispos 35:1679-1686.
67. Oguri, K., Kurogi, A., Yamabe, K., Tanaka, M., Yoshisue, K., Ishii, Y., et al. (1996). Purifcation of a phenobarbital-inducible UDP- glucuronosyltransferase isoform from dog liver which catalyzes morphine and testosterone glucuronidation. Arch Biochem Biophys 325:159-166.
68. Oguri, K., Yamada, H., Yoshimura, H. (1994). Regiochemistry of cytochrome P450 isozymes. Annu Rev Pharmacol Toxicol 34:251-279.
69. Okamura, K., Ishii, Y., Ikushiro, S., Mackenzie, P. I., Yamada, H. (2006). Fatty acyl-CoA as an endogenous activator of UDP- glucuronosyltransferases. Biochem Biophys Res Commun 345:1649-1656.
70. Operaña, T. N., Tukey, R. H. (2007). Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo-and heterodimeri-zation analysis by fuorescence resonance energy transfer and coimmunoprecipitation. J Biol Chem 282:4821-4829.
71. Ouzzine, M., Magdalou, J., Burchell, B., Fournel-Gigleux, S. (1999). An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplas-mic reticulum. J Biol Chem 274:31401-31409.
72. Peters, W. H., Jansen, P. L., Nauta, H. (1984). Te molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase. J Biol Chem 259:11701-11705.
73. Puig, J. F., Tephly, T. R. (1986). Isolation and purifcation of rat-liver morphine UDP-glucuronosyltransferase. Mol Pharmacol 30:558-565.
74. Radominska-Pandya, A., Bratton, S., Little, J. M. (2005). A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years. Curr Drug Metab 6:141-160.
75. Satoh, T., Hosokawa, M. (1998). Te mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol 38:257-288.
76. Seidegård, J., DePierre, J. W. (1983). Microsomal epoxide hydrolase. Properties, regulation, and function. Biochim Biophys Acta 695:251-270.
77. Shepherd, S. R., Baird, S. J., Hallinan, T., Burchell, B. (1989). An investigation of the transverse topology of bilirubin UDP- glucuronosyltransferase in rat hepatic endoplasmic reticulum. Biochem J 259:617-620.
78. Shimomura, K., Kamata, O., Ueki, S., Ida, S., Oguri, K., Yoshimura, H., et al. (1971). Analgesic efect of morphine glucuronides. Tohoku J Exp Med 105:45-52.
79. Soars, M. G., Barbara, B. J., Ring, J., Wrighton, S. A. (2003). Te efect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases. Drug Metab Dispos 31:762-767.
80. Subramanian, M., Low, M., Locuson, C. W., Tracy, T. S. (2009). CYP2D6-CYP2C9 protein-protein interactions and isoform-se-lective efects on substrate binding and catalysis. Drug Metab Dispos 37: 1682-1689.
81. Takeda, S., Ishii, Y., Iwanaga, M., Mackenzie, P. I., Nagata, K., Yamazoe, Y., et al. (2005a). Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4. Mol Pharmacol 67:665-672.
82. Takeda, S., Ishii, Y., Mackenzie, P. I., Nagata, K., Yamazoe, Y., Oguri, K., et al. (2005b). Modulation of UDP-glucuronosyltransferase 2B7 function by cytochrome P450s in vitro: diferential efects of CYP1A2, CYP2C9, and CYP3A4. Biol Pharm Bull 28:2026-2027.
83. Takeda, S., Ishii, Y., Iwanaga, M., Nurrochmad, A., Ito, Y., Mackenzie, P. I., et al. (2009). Interaction of cytochrome P450 3A4 and UDP-glucuronosyltransferase 2B7: evidence for protein-protein association and possible involvement of CYP3A4 J-helix in the interaction. Mol Pharmacol 75:956-964.
84. Tan, Y., Patten, C. J., Smith, T., Yang, C. S. (1997). Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system. Arch Biochem Biophys 342:82-91.
85. Taura, K., Naito, E., Ishii Y., Mori, M. A., Oguri, K., Yamada, H. (2004). Cytochrome P450 1A1 (CYP1A1) inhibitor alpha-naphthofa-vone interferes with UDP-glucuronosyltransferase (UGT) activity in intact, but not in permeabilized hepatic microsomes, from 3-methylcholanthrene-treated rats: possible involvement of UGT-P450 interactions. Biol Pharm Bull 27:56-60.
86. Taura, K., Yamada, H., Hagino, Y., Ishii, Y., Mori, M., Oguri, K. (2000). Interaction between cytochrome P450 and other drug-metabolizing enzymes: evidence for an association of CYP1A1 with micro-somal epoxide hydrolase and UDP-glucuronosyltransferase. Biochem Biophys Res Commun 273:1048-1052.
87. Vanstapel, F., Blanckaert, N. (1988). Topology and regulation of bilirubin UDP-glucuronyltransferase in sealed native micro-somes from rat liver. Arch Biochem Biophys 263:216-225.
88. Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J. M., Evans, D.A., Grant, D. M., et al. (1995). Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1-17.
89. Whalen, R., Boyer, T. D. (1998). Human glutathione S-transferases. Semin Liver Dis 18:345-358.
90. Williams, P. A., Cosme, J., Sridhar, V., Johnson, E. F., McRee, D. E. (2000). Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol Cell 5:121-131.
91. Williams, P. A., Cosme, J., Vinkovic, D. M., Ward, A., Angove, H. C., Day, P. J., et al. (2004). Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science 305:683-686.
92. Yamazaki, H., Gillam, E. M. J., Dong, M.-S., Johnson, W. W., Guengerich, F. P., Shimada, T. (1997). Reconstitution of recom-binant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: efects of cytochrome P450-P450 and cytochrome P450-b5 interactions. Arch Biochem Biophys 342:329-337.
93. Yano, J. K., Wester, M. R., Schoch, G. A., Grifn, K. J., Stout, C. D., Johnson, E. F. (2004). Te structure of human microsomal cyto-chrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem 279:38091-38094.
94. Yoshinari, K., Petrotchenko, E. V., Pedersen, L. C., Negishi, M. (2001). Crystal structure-based studies of cytosolic sulfotransferase. J Biochem Mol Toxicol 15:67-75